购物车
- 全部删除
- 您的购物车当前为空
Eriosemation significant androgen receptor (AR) inhibition activity, suggests that it could be a promising candidate for further evaluation for prostate cancer prevention or management.
Eriosemation significant androgen receptor (AR) inhibition activity, suggests that it could be a promising candidate for further evaluation for prostate cancer prevention or management.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 3,710 | 期货 | |
1 mL x 10 mM (in DMSO) | ¥ 3,810 | 期货 |
产品描述 | Eriosemation significant androgen receptor (AR) inhibition activity, suggests that it could be a promising candidate for further evaluation for prostate cancer prevention or management. |
别名 | 鲁冰花, 5,7-二羟基-6,8-二异戊烯基色原酮, 5,7-Dihydroxy-6,8-diprenylchromone |
分子量 | 314.38 |
分子式 | C19H22O4 |
CAS No. | 162616-72-0 |
密度 | 1.184 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容